Beam Therapeutics Statistics
NASDAQ: BEAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
24.77-0.46 (-1.82%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 24.07 -2.83%
Beam Therapeutics by the numbers
Beam Therapeutics has a market capitalization of $2.56 billion based on 103.29M shares outstanding. With trailing EPS of $-0.68, Beam Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.8% below its 50-day average and 13.0% below its 200-day average.
Average daily trading volume is 1.91M shares, or about $47.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BEAM valuation vs. peer median
| Metric | BEAM | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.56B | $2.12B | +21% |
| Avg. volume | 1.91M | 2.25M | -15% |
Peer median across 8 companies: RXRX, ADMA, DNLI, BCRX, ALVO, VCEL, VIR, NVAX.
Valuation
- Market cap
- $2.56B
- Price / sales (latest FY)
- 18.31
- EPS (TTM)
- $-0.68
- Shares outstanding
- 103.29M
Price and trading
- Previous close
- 25.23
- Open
- 24.64
- Day range
- 24.45 – 25.37
- 52-week range
- 20.23 – 38.26
- 52-week change
- -1.43%
- Beta
- —
- Volume
- 2.34M
- Average volume
- 1.91M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 2.56B
- Forward Pe
- -5.22
- Eps
- -0.68
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 38.26
- Week52 Low
- 20.23
- Avg Volume
- 1.91M
- Shares Outstanding
- 103.29M
- Ma50
- 26.59
- Ma200
- 28.47
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -35.26%
- Pct From52w Low
- 22.44%